<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2300</number>
    <updateDate>2023-01-13T04:49:04Z</updateDate>
    <updateDateIncludingText>2023-01-13T04:49:04Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2006-02-16</introducedDate>
    <congress>109</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2006-02-16T19:31:12Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Lower PRICED Drugs Act</title>
        <congress>109</congress>
        <number>6022</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2006-08-01</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2006-02-27</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Star Print ordered on the bill.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1421-1422)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Sponsor introductory remarks on measure. (CR S1420-1421)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2006-02-16</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S000770</bioguideId>
        <fullName>Sen. Stabenow, Debbie [D-MI]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Stabenow</lastName>
        <party>D</party>
        <state>MI</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>L000447</bioguideId>
        <fullName>Sen. Lott, Trent [R-MS]</fullName>
        <firstName>CHESTER</firstName>
        <lastName>LOTT</lastName>
        <party>R</party>
        <state>MS</state>
        <middleName>TRENT</middleName>
        <sponsorshipDate>2006-02-16</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000305</bioguideId>
        <fullName>Sen. Kohl, Herb [D-WI]</fullName>
        <firstName>HERBERT</firstName>
        <lastName>KOHL</lastName>
        <party>D</party>
        <state>WI</state>
        <middleName>H.</middleName>
        <sponsorshipDate>2006-03-13</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Antibiotics</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Consumer education</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drug utilization</name>
        </item>
        <item>
          <name>Families</name>
        </item>
        <item>
          <name>Generic drugs</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Marketing</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Patents</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2006-02-16</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2006-04-20T18:39:06Z</updateDate>
        <text><![CDATA[ <p>Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act or the Lower PRICED Drugs Act - Amends the Federal Food, Drug, and Cosmetic Act to require an abbreviated application for a new drug containing certain antibiotics, the approved labeling for which includes a method of use that is claimed by a patent, to include a statement: (1) that identifies the relevant patent and the approved use covered by the patent; and (2) that the applicant is not seeking approval of such use.</p> <p> Requires the court to consider the totality of circumstances and the public interest in deciding whether to shorten the 30-month period that delays the approval of an abbreviated drug application when a patent infringement case is filed against the applicant.</p> <p>Limits market exclusivity provided for conducting pediatric studies of new drugs to only those new drugs for which the Secretary of Health and Human Services approves labeling that contains specific, therapeutically meaningful information about the use of the drug product in pediatric patients.</p> <p>Prohibits the Secretary from delaying the approval of a new drug application while a petition is reviewed and considered. Requires the Secretary to take final agency action on a petition within six months of receipt, with no extensions allowed. Extends the 30-month period that the Secretary has to approve or disapprove an abbreviated application for a new drug by the amount of time that lapses from the date the Secretary receives a petition and the date of the final agency action on the petition, without regard to whether the Secretary grants or denies the petition.</p>]]></text>
      </summary>
    </summaries>
    <title>Lower PRICED Drugs Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Lower PRICED Drugs Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to market exclusivity for certain drugs, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Lower PRICED Drugs Act</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Lower Prices Reduced with Increased Competition and Efficient Development of Drugs Act</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2006-02-16T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-109s2300is/xml/BILLS-109s2300is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2006-02-27</actionDate>
      <text>Star Print ordered on the bill.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
